Cargando…

Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation

BACKGROUND: Recommending the optimal treatment for an individual patient requires a well-balanced consideration of various medical, social and ethical factors. The interplay of these factors, interpretation of the patient’s situation and understanding of the existing clinical guidelines can lead to...

Descripción completa

Detalles Bibliográficos
Autores principales: Otte, I., Salloch, S., Reinacher-Schick, A., Vollmann, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699200/
https://www.ncbi.nlm.nih.gov/pubmed/29162047
http://dx.doi.org/10.1186/s12885-017-3783-6
_version_ 1783280903141720064
author Otte, I.
Salloch, S.
Reinacher-Schick, A.
Vollmann, J.
author_facet Otte, I.
Salloch, S.
Reinacher-Schick, A.
Vollmann, J.
author_sort Otte, I.
collection PubMed
description BACKGROUND: Recommending the optimal treatment for an individual patient requires a well-balanced consideration of various medical, social and ethical factors. The interplay of these factors, interpretation of the patient’s situation and understanding of the existing clinical guidelines can lead to divergent therapy recommendations, depending on the attending physician. Gaining a better understanding of the individual process of medical decision-making and the differences occurring will support the delivery of optimal individualized care within the clinical setting. METHODS: A case vignette of a 64-year-old patient with locally advanced pancreatic adenocarcinoma was discussed with oncologists in 14 qualitative, semi-structured interviews at two academic institutions. Relevant factors that emerged were ranked by the participants using the Q card sorting method. Qualitative data analysis and descriptive statistics were performed. RESULTS: Oncologists recommend different therapeutic approaches within the leeway of the relevant clinical guidelines. One group of participants endorses a rather aggressive and potentially curative approach with a combination chemotherapy following the FOLFIRINOX protocol to provide the patient with the best chances of resectability. The second group suggests a milder chemotherapy approach with gemcitabine, highlighting the palliative approach and the patient’s quality of life. Clinical guidelines are generally seen as an important point of reference, but are complicated to apply in highly individual cases. CONCLUSION: The physician’s individual assessment of factors, such as biological age, general condition or prognosis, plays a decisive role in treatment recommendations, particularly in those cases which are not fully covered by guidelines. Judgment and discretion remain crucial in clinical decision-making and cannot and should not be fully ruled out by evidence-based guidelines. Therefore, a more comprehensive reflection on the interaction between evidence-based medicine and the physician’s estimation of each individual case is desirable. Knowledge of existing barriers can enhance the implementation of guidelines, for example, through medical education. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-017-3783-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5699200
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56992002017-12-01 Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation Otte, I. Salloch, S. Reinacher-Schick, A. Vollmann, J. BMC Cancer Research Article BACKGROUND: Recommending the optimal treatment for an individual patient requires a well-balanced consideration of various medical, social and ethical factors. The interplay of these factors, interpretation of the patient’s situation and understanding of the existing clinical guidelines can lead to divergent therapy recommendations, depending on the attending physician. Gaining a better understanding of the individual process of medical decision-making and the differences occurring will support the delivery of optimal individualized care within the clinical setting. METHODS: A case vignette of a 64-year-old patient with locally advanced pancreatic adenocarcinoma was discussed with oncologists in 14 qualitative, semi-structured interviews at two academic institutions. Relevant factors that emerged were ranked by the participants using the Q card sorting method. Qualitative data analysis and descriptive statistics were performed. RESULTS: Oncologists recommend different therapeutic approaches within the leeway of the relevant clinical guidelines. One group of participants endorses a rather aggressive and potentially curative approach with a combination chemotherapy following the FOLFIRINOX protocol to provide the patient with the best chances of resectability. The second group suggests a milder chemotherapy approach with gemcitabine, highlighting the palliative approach and the patient’s quality of life. Clinical guidelines are generally seen as an important point of reference, but are complicated to apply in highly individual cases. CONCLUSION: The physician’s individual assessment of factors, such as biological age, general condition or prognosis, plays a decisive role in treatment recommendations, particularly in those cases which are not fully covered by guidelines. Judgment and discretion remain crucial in clinical decision-making and cannot and should not be fully ruled out by evidence-based guidelines. Therefore, a more comprehensive reflection on the interaction between evidence-based medicine and the physician’s estimation of each individual case is desirable. Knowledge of existing barriers can enhance the implementation of guidelines, for example, through medical education. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-017-3783-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-11-21 /pmc/articles/PMC5699200/ /pubmed/29162047 http://dx.doi.org/10.1186/s12885-017-3783-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Otte, I.
Salloch, S.
Reinacher-Schick, A.
Vollmann, J.
Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation
title Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation
title_full Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation
title_fullStr Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation
title_full_unstemmed Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation
title_short Treatment recommendations within the leeway of clinical guidelines: A qualitative interview study on oncologists’ clinical deliberation
title_sort treatment recommendations within the leeway of clinical guidelines: a qualitative interview study on oncologists’ clinical deliberation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699200/
https://www.ncbi.nlm.nih.gov/pubmed/29162047
http://dx.doi.org/10.1186/s12885-017-3783-6
work_keys_str_mv AT ottei treatmentrecommendationswithintheleewayofclinicalguidelinesaqualitativeinterviewstudyononcologistsclinicaldeliberation
AT sallochs treatmentrecommendationswithintheleewayofclinicalguidelinesaqualitativeinterviewstudyononcologistsclinicaldeliberation
AT reinacherschicka treatmentrecommendationswithintheleewayofclinicalguidelinesaqualitativeinterviewstudyononcologistsclinicaldeliberation
AT vollmannj treatmentrecommendationswithintheleewayofclinicalguidelinesaqualitativeinterviewstudyononcologistsclinicaldeliberation